Celecoxib ameliorates seizure susceptibility in autosomal dominant lateral temporal epilepsy

Lin Zhou, Liang Zhou, Li Da Su, Sheng Long Cao, Ya Jun Xie, Na Wang, Chong Yu Shao, Ya Nan Wang, Jia Huan Zhou, John Kenneth Cowell, Ying Shen

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Autosomal dominant lateral temporal epilepsy (ADLTE) is an inherited syndrome caused by mutations in the leucine-rich glioma inactivated 1 (LGI1) gene. It is known that glutamatergic transmission is altered in LGI1 mutant mice, and seizures can be reduced by restoring LGI1 function. Yet, the mechanism underlying ADLTE is unclear. Here, we propose that seizures in male LGI1-/-mice are due to nonsynaptic epileptiform activity in cortical neurons. We examined the intrinsic excitability of pyramidal neurons in the temporal cortex of male LGI1-/-mice and found that the voltage-gated K+channel Kv1.2 was significantly downregulated. We also found that cytosolic phospholipase A2(cPLA2)-cyclooxygenase 2 (Cox2) signaling was enhanced in LGI1-/-mice. Interestingly, Cox2 inhibition effectively restored the dysregulated Kv1.2 and reduced the intrinsic excitability of pyramidal neurons. Moreover, in vivo injection of celecoxib, an FDA-approved nonsteroidal anti-inflammatory drug, rescued the defective Kv1.2 (an ~1.9-fold increase), thereby alleviating the seizure susceptibility and extending the life of LGI1-/-mice by 5 d. In summary, we conclude that LGI1 deficiency dysregulates cPLA2-Cox2 signaling to cause hyperexcitability of cortical pyramidal neurons, and celecoxib is a potential agent to manage human ADLTE.

Original languageEnglish (US)
Pages (from-to)3346-3357
Number of pages12
JournalJournal of Neuroscience
Volume38
Issue number13
DOIs
StatePublished - Mar 28 2018

Fingerprint

Celecoxib
Temporal Lobe Epilepsy
Leucine
Glioma
Seizures
Pyramidal Cells
Cyclooxygenase 2
Cytosolic Phospholipases A2
Voltage-Gated Potassium Channels
Temporal Lobe

Keywords

  • ADLTE
  • Celecoxib
  • Cox2
  • Epilepsy
  • Kv1.2

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Zhou, L., Zhou, L., Su, L. D., Cao, S. L., Xie, Y. J., Wang, N., ... Shen, Y. (2018). Celecoxib ameliorates seizure susceptibility in autosomal dominant lateral temporal epilepsy. Journal of Neuroscience, 38(13), 3346-3357. https://doi.org/10.1523/JNEUROSCI.3245-17.2018

Celecoxib ameliorates seizure susceptibility in autosomal dominant lateral temporal epilepsy. / Zhou, Lin; Zhou, Liang; Su, Li Da; Cao, Sheng Long; Xie, Ya Jun; Wang, Na; Shao, Chong Yu; Wang, Ya Nan; Zhou, Jia Huan; Cowell, John Kenneth; Shen, Ying.

In: Journal of Neuroscience, Vol. 38, No. 13, 28.03.2018, p. 3346-3357.

Research output: Contribution to journalArticle

Zhou, L, Zhou, L, Su, LD, Cao, SL, Xie, YJ, Wang, N, Shao, CY, Wang, YN, Zhou, JH, Cowell, JK & Shen, Y 2018, 'Celecoxib ameliorates seizure susceptibility in autosomal dominant lateral temporal epilepsy', Journal of Neuroscience, vol. 38, no. 13, pp. 3346-3357. https://doi.org/10.1523/JNEUROSCI.3245-17.2018
Zhou, Lin ; Zhou, Liang ; Su, Li Da ; Cao, Sheng Long ; Xie, Ya Jun ; Wang, Na ; Shao, Chong Yu ; Wang, Ya Nan ; Zhou, Jia Huan ; Cowell, John Kenneth ; Shen, Ying. / Celecoxib ameliorates seizure susceptibility in autosomal dominant lateral temporal epilepsy. In: Journal of Neuroscience. 2018 ; Vol. 38, No. 13. pp. 3346-3357.
@article{34bc7fc64ac243e99a93b2e4d8a855b2,
title = "Celecoxib ameliorates seizure susceptibility in autosomal dominant lateral temporal epilepsy",
abstract = "Autosomal dominant lateral temporal epilepsy (ADLTE) is an inherited syndrome caused by mutations in the leucine-rich glioma inactivated 1 (LGI1) gene. It is known that glutamatergic transmission is altered in LGI1 mutant mice, and seizures can be reduced by restoring LGI1 function. Yet, the mechanism underlying ADLTE is unclear. Here, we propose that seizures in male LGI1-/-mice are due to nonsynaptic epileptiform activity in cortical neurons. We examined the intrinsic excitability of pyramidal neurons in the temporal cortex of male LGI1-/-mice and found that the voltage-gated K+channel Kv1.2 was significantly downregulated. We also found that cytosolic phospholipase A2(cPLA2)-cyclooxygenase 2 (Cox2) signaling was enhanced in LGI1-/-mice. Interestingly, Cox2 inhibition effectively restored the dysregulated Kv1.2 and reduced the intrinsic excitability of pyramidal neurons. Moreover, in vivo injection of celecoxib, an FDA-approved nonsteroidal anti-inflammatory drug, rescued the defective Kv1.2 (an ~1.9-fold increase), thereby alleviating the seizure susceptibility and extending the life of LGI1-/-mice by 5 d. In summary, we conclude that LGI1 deficiency dysregulates cPLA2-Cox2 signaling to cause hyperexcitability of cortical pyramidal neurons, and celecoxib is a potential agent to manage human ADLTE.",
keywords = "ADLTE, Celecoxib, Cox2, Epilepsy, Kv1.2",
author = "Lin Zhou and Liang Zhou and Su, {Li Da} and Cao, {Sheng Long} and Xie, {Ya Jun} and Na Wang and Shao, {Chong Yu} and Wang, {Ya Nan} and Zhou, {Jia Huan} and Cowell, {John Kenneth} and Ying Shen",
year = "2018",
month = "3",
day = "28",
doi = "10.1523/JNEUROSCI.3245-17.2018",
language = "English (US)",
volume = "38",
pages = "3346--3357",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "13",

}

TY - JOUR

T1 - Celecoxib ameliorates seizure susceptibility in autosomal dominant lateral temporal epilepsy

AU - Zhou, Lin

AU - Zhou, Liang

AU - Su, Li Da

AU - Cao, Sheng Long

AU - Xie, Ya Jun

AU - Wang, Na

AU - Shao, Chong Yu

AU - Wang, Ya Nan

AU - Zhou, Jia Huan

AU - Cowell, John Kenneth

AU - Shen, Ying

PY - 2018/3/28

Y1 - 2018/3/28

N2 - Autosomal dominant lateral temporal epilepsy (ADLTE) is an inherited syndrome caused by mutations in the leucine-rich glioma inactivated 1 (LGI1) gene. It is known that glutamatergic transmission is altered in LGI1 mutant mice, and seizures can be reduced by restoring LGI1 function. Yet, the mechanism underlying ADLTE is unclear. Here, we propose that seizures in male LGI1-/-mice are due to nonsynaptic epileptiform activity in cortical neurons. We examined the intrinsic excitability of pyramidal neurons in the temporal cortex of male LGI1-/-mice and found that the voltage-gated K+channel Kv1.2 was significantly downregulated. We also found that cytosolic phospholipase A2(cPLA2)-cyclooxygenase 2 (Cox2) signaling was enhanced in LGI1-/-mice. Interestingly, Cox2 inhibition effectively restored the dysregulated Kv1.2 and reduced the intrinsic excitability of pyramidal neurons. Moreover, in vivo injection of celecoxib, an FDA-approved nonsteroidal anti-inflammatory drug, rescued the defective Kv1.2 (an ~1.9-fold increase), thereby alleviating the seizure susceptibility and extending the life of LGI1-/-mice by 5 d. In summary, we conclude that LGI1 deficiency dysregulates cPLA2-Cox2 signaling to cause hyperexcitability of cortical pyramidal neurons, and celecoxib is a potential agent to manage human ADLTE.

AB - Autosomal dominant lateral temporal epilepsy (ADLTE) is an inherited syndrome caused by mutations in the leucine-rich glioma inactivated 1 (LGI1) gene. It is known that glutamatergic transmission is altered in LGI1 mutant mice, and seizures can be reduced by restoring LGI1 function. Yet, the mechanism underlying ADLTE is unclear. Here, we propose that seizures in male LGI1-/-mice are due to nonsynaptic epileptiform activity in cortical neurons. We examined the intrinsic excitability of pyramidal neurons in the temporal cortex of male LGI1-/-mice and found that the voltage-gated K+channel Kv1.2 was significantly downregulated. We also found that cytosolic phospholipase A2(cPLA2)-cyclooxygenase 2 (Cox2) signaling was enhanced in LGI1-/-mice. Interestingly, Cox2 inhibition effectively restored the dysregulated Kv1.2 and reduced the intrinsic excitability of pyramidal neurons. Moreover, in vivo injection of celecoxib, an FDA-approved nonsteroidal anti-inflammatory drug, rescued the defective Kv1.2 (an ~1.9-fold increase), thereby alleviating the seizure susceptibility and extending the life of LGI1-/-mice by 5 d. In summary, we conclude that LGI1 deficiency dysregulates cPLA2-Cox2 signaling to cause hyperexcitability of cortical pyramidal neurons, and celecoxib is a potential agent to manage human ADLTE.

KW - ADLTE

KW - Celecoxib

KW - Cox2

KW - Epilepsy

KW - Kv1.2

UR - http://www.scopus.com/inward/record.url?scp=85044730842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044730842&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.3245-17.2018

DO - 10.1523/JNEUROSCI.3245-17.2018

M3 - Article

VL - 38

SP - 3346

EP - 3357

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 13

ER -